ACOR - Acorda Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts6666
Avg. Estimate0.470.850.13-2.02
Low Estimate0.090.39-0.15-4.35
High Estimate1.021.340.620.81
Year Ago EPS-0.080.291.750.13
Revenue EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts1010109
Avg. Estimate129.87M147.75M369.66M150.12M
Low Estimate116.3M120.3M343.3M85.3M
High Estimate148.6M163.2M406.79M261.61M
Year Ago Sales119.39M139.44M588.29M369.66M
Sales Growth (year/est)8.80%6.00%-37.20%-59.40%
Earnings History3/30/20176/29/20179/29/201712/30/2017
EPS Est.0.090.480.651.05
EPS Actual-0.080.290.430.61
Difference-0.17-0.19-0.22-0.44
Surprise %-188.90%-39.60%-33.80%-41.90%
EPS TrendCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Current Estimate0.470.850.13-2.02
7 Days Ago0.470.850.13-2.02
30 Days Ago0.550.940.17-2.59
60 Days Ago0.60.950.76-2.4
90 Days Ago0.681.090.93-2.51
EPS RevisionsCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesACORIndustrySectorS&P 500
Current Qtr.687.50%N/AN/A0.42
Next Qtr.193.10%N/AN/A0.38
Current Year-92.60%N/AN/A0.20
Next Year-1,653.80%N/AN/A0.10
Next 5 Years (per annum)29.00%N/AN/A0.12
Past 5 Years (per annum)44.63%N/AN/AN/A